552 related articles for article (PubMed ID: 16928407)
21. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
Ritter U; Meissner A; Scheidig C; Körner H
Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
[TBL] [Abstract][Full Text] [Related]
22. Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells.
Tripp CH; Sparber F; Hermans IF; Romani N; Stoitzner P
J Immunol; 2009 Jun; 182(12):7644-54. PubMed ID: 19494288
[TBL] [Abstract][Full Text] [Related]
23. Instruction of naive CD4+ T cells by polarized CD4+ T cells within dendritic cell clusters.
Creusot RJ; Biswas JS; Thomsen LL; Tite JP; Mitchison NA; Chain BM
Eur J Immunol; 2003 Jun; 33(6):1686-96. PubMed ID: 12778487
[TBL] [Abstract][Full Text] [Related]
24. The role of skin-derived dendritic cells in CD8+ T cell priming following immunization with lentivectors.
Furmanov K; Elnekave M; Lehmann D; Clausen BE; Kotton DN; Hovav AH
J Immunol; 2010 May; 184(9):4889-97. PubMed ID: 20357252
[TBL] [Abstract][Full Text] [Related]
25. Human Flt-3-ligand-mobilized dendritic cells require additional activation to drive effective immune responses.
Diener KR; Moldenhauer LM; Lyons AB; Brown MP; Hayball JD
Exp Hematol; 2008 Jan; 36(1):51-60. PubMed ID: 17949888
[TBL] [Abstract][Full Text] [Related]
26. IL-2 production by dendritic cells is not critical for the activation of cognate and innate effectors in draining lymph nodes.
Schartz NE; Chaput N; Taieb J; Bonnaventure P; Trébeden-Nègre H; Terme M; Ménard C; Lebbé C; Schimpl A; Ardouin P; Zitvogel L
Eur J Immunol; 2005 Oct; 35(10):2840-50. PubMed ID: 16163668
[TBL] [Abstract][Full Text] [Related]
27. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse.
Joussemet B; Vu AT; Sai P; Bach JM
Ann N Y Acad Sci; 2005 Jun; 1051():613-25. PubMed ID: 16127002
[TBL] [Abstract][Full Text] [Related]
28. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
[TBL] [Abstract][Full Text] [Related]
29. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin.
Ross R; Sudowe S; Beisner J; Ross XL; Ludwig-Portugall I; Steitz J; Tüting T; Knop J; Reske-Kunz AB
Gene Ther; 2003 Jun; 10(12):1035-40. PubMed ID: 12776161
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of both cellular and humoral responses to genetic immunization by co-administration of an antigen-expressing plasmid and a plasmid encoding the pro-apoptotic protein Bax.
Kinsey BM; Marcelli M; Song L; Bhogal BS; Ittmann M; Orson FM
J Gene Med; 2004 Apr; 6(4):445-54. PubMed ID: 15079819
[TBL] [Abstract][Full Text] [Related]
32. Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization.
Ross HM; Weber LW; Wang S; Piskun G; Dyall R; Song P; Takechi Y; Nikolić-Zugić J; Houghton AN; Lewis JJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2191-6. PubMed ID: 9815614
[TBL] [Abstract][Full Text] [Related]
33. In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses.
Esslinger C; Chapatte L; Finke D; Miconnet I; Guillaume P; Lévy F; MacDonald HR
J Clin Invest; 2003 Jun; 111(11):1673-81. PubMed ID: 12782670
[TBL] [Abstract][Full Text] [Related]
34. Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells.
Heemskerk MH; Hooijberg E; Ruizendaal JJ; van der Weide MM; Kueter E; Bakker AQ; Schumacher TN; Spits H
Cell Immunol; 1999 Jul; 195(1):10-7. PubMed ID: 10433792
[TBL] [Abstract][Full Text] [Related]
35. Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.
Sudowe S; Dominitzki S; Montermann E; Bros M; Grabbe S; Reske-Kunz AB
Immunology; 2009 Sep; 128(1 Suppl):e193-205. PubMed ID: 18800984
[TBL] [Abstract][Full Text] [Related]
36. Immunization with dendritic cells retrovirally transduced with mycobacterial antigen 85A gene elicits the specific cellular immunity including cytotoxic T-lymphocyte activity specific to an epitope on antigen 85A.
Nakano H; Nagata T; Suda T; Tanaka T; Aoshi T; Uchijima M; Kuwayama S; Kanamaru N; Chida K; Nakamura H; Okada M; Koide Y
Vaccine; 2006 Mar; 24(12):2110-9. PubMed ID: 16352377
[TBL] [Abstract][Full Text] [Related]
37. In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine.
Cayeux S; Bukarica B; Buschow C; Charo J; Bunse M; Dörken B; Blankenstein T
Gene Ther; 2007 Oct; 14(20):1481-91. PubMed ID: 17700709
[TBL] [Abstract][Full Text] [Related]
38. Enhanced antigen-specific antibody production following polyplex-based DNA vaccination via the intradermal route in mice.
Kawase A; Isaji K; Yamaoka A; Kobayashi N; Nishikawa M; Takakura Y
Vaccine; 2006 Jul; 24(27-28):5535-45. PubMed ID: 16716462
[TBL] [Abstract][Full Text] [Related]
39. RNA-containing adenovirus/polyethylenimine transfer complexes effectively transduce dendritic cells and induce antigen-specific T cell responses.
Gust TC; Diebold SS; Cotten M; Zenke M
J Gene Med; 2004 Apr; 6(4):464-70. PubMed ID: 15079821
[TBL] [Abstract][Full Text] [Related]
40. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
Kim S; Lee JB; Lee GK; Chang J
Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
